Yat Sun Or
Chief Scientific Officer · ENANTA PHARMACEUTICALS INC
- 2024
- Feb 13, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yat Sun Or files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jay R. Luly - $67K in ENTA purchases and sales in the last 12 months
- Tara Lynn Kieffer - $30K in ENTA purchases and sales in the last 12 months
- Brendan Luu - $20K in ENTA purchases and sales in the last 12 months
- Harry R. Trout III - $13K in ENTA purchases and sales in the last 12 months
- Scott T. Rottinghaus - $11K in ENTA purchases and sales in the last 12 months
- Kathleen S. Capps - $7K in ENTA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yat Sun Or?
Yat Sun Or is a corporate insider, tracked as Chief Scientific Officer of ENANTA PHARMACEUTICALS INC (ENTA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Yat Sun Or last file a Form 4?
The most recent primary Form 4 on record is dated 13 February 2026, one of 7 filings going back to 2024.
Has Yat Sun Or been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($55K) across all tracked filings.
